Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications-A systematic review

被引：9
作者：
Ramanathan, Kumaresan [1 ]
Padmanabhan, Giri [2 ]
机构：
[1] Mekelle Univ, Dept Med Biochem, Div Biomed Sci, Sch Med,Coll Hlth Sci, Ayder Campus, Mekelle, Ethiopia
[2] Kidney Care, C50,10th B Cross, Tiruchirappalli, Tamil Nadu, India
来源：
INDIAN HEART JOURNAL | 2020年 / 72卷 / 01期
关键词：
Soluble neprilysin; Biomarker; Heart failure; Diabetic kidney disease; A systematic review; ANGIOTENSIN-CONVERTING ENZYME; VASOPEPTIDASE INHIBITOR OMAPATRILAT; RESUSCITATION COUNCIL GUIDELINES; NEUTRAL ENDOPEPTIDASE; ALDOSTERONE SYNTHESIS; INSULIN SENSITIVITY; CELLS; HYDROLYSIS; MIXANPRIL; FIBROSIS;
D O I：
10.1016/j.ihj.2020.01.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The potential role of soluble neprilysin (sNEP) as a biomarker has been poorly documented. Hence, the present systematic review emphasizes to explore sNEP as an emerging biomarker for heart failure (HF), cardiovascular diseases, diabetic kidney diseases, and so on. A systematic review was performed using an online database search in PubMed, Science Direct, Scopus, and Cochrane Library. Articles reporting biomarker's performance to diagnose various diseases in human participants were included. The results of the search outcome were 4723 articles. Based on the inclusion criteria of the systematic review, finally, 12 articles fulfilled the selection criteria. In these studies, 8 cohort study, 2 cross-sectional study, 1 case econtrol, and 1 prospective cohort study were identified. All these studies clearly suggested sNEP as a potential biomarker for diagnosis of various diseases (HF, cardiovascular diseases, diabetic kidney diseases, metabolic syndrome). sNEP may be a potential biomarker for HF, cardiovascular diseases, diabetic kidney disease, and so on. (C) 2020 Cardiological Society of India. Published by Elsevier B.V.
引用
收藏
页码：14 / 19
页数：6
相关论文
共 43 条
  • [1] Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats
    Arbin, V
    Claperon, N
    Fournié-Zaluski, MC
    Roques, BP
    Peyroux, J
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (02) : 254 - 264
  • [2] Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat
    Arbin, V
    Claperon, N
    Fournié-Zaluski, MC
    Roques, BP
    Peyroux, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (04) : 495 - 502
  • [3] URINARY NEUTRAL ENDOPEPTIDASE-24.11 ACTIVITY - MODULATION BY CHRONIC SALT LOADING
    AVIV, R
    GURBANOV, K
    HOFFMAN, A
    BLUMBERG, S
    WINAVER, J
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (03) : 855 - 860
  • [4] Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction
    Bäcklund, T
    Palojoki, E
    Saraste, A
    Grönholm, T
    Eriksson, A
    Lakkisto, P
    Vuolteenaho, O
    Nieminen, MS
    Voipio-Pulkki, LM
    Laine, M
    Tikkanen, I
    [J]. CARDIOVASCULAR RESEARCH, 2003, 57 (03) : 727 - 737
  • [5] Soluble neprilysin retains catalytic activity in heart failure
    Bayes-Genis, Antoni
    Prickett, Timothy C.
    Richards, A. Mark
    Barallat, Jaume
    Lupon, Josep
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (05) : 684 - 685
  • [6] Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP
    Bayes-Genis, Antoni
    Barallat, Jaume
    Galan, Amparo
    de Antonio, Marta
    Domingo, Mar
    Zamora, Elisabet
    Gastelurrutia, Paloma
    Vila, Joan
    Penafiel, Judith
    Galvez-Monton, Carolina
    Lupon, Josep
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (12): : 1075 - 1084
  • [7] Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure A Pilot Study
    Bayes-Genis, Antoni
    Barallat, Jaume
    Pascual-Figal, Domingo
    Nunez, Julio
    Minana, Gema
    Sanchez-Mas, Jesus
    Galan, Amparo
    Sanchis, Juan
    Zamora, Elisabet
    Teresa Perez-Martinez, Maria
    Lupon, Josep
    [J]. JACC-HEART FAILURE, 2015, 3 (08) : 641 - 644
  • [8] Soluble Neprilysin Is Predictive of Cardiovascular Death and Heart Failure Hospitalization in Heart Failure Patients
    Bayes-Genis, Antoni
    Barallat, Jaume
    Galan, Amparo
    de Antonio, Marta
    Domingo, Mar
    Zamora, Elisabet
    Urrutia, Agustin
    Lupon, Josep
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (07) : 657 - 665
  • [9] Collins AJ, 2006, NATL MED J INDIA, V19, P55
  • [10] Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction
    Goliasch, Georg
    Pavo, Noemi
    Zotter-Tufaro, Caroline
    Kammerlander, Andreas
    Duca, Franz
    Mascherbauer, Julia
    Bonderman, Diana
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (01) : 89 - 93
12345